Raul Rabadan

This inventor holds 8 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Columbia University, Institute for Advanced Study, Institute of Advanced Study. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raul Rabadan. Retrieved from https://idiyas.com/inventor/raul-rabadan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 10)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Princeton, NJ (US) (2016)
New York, NY (US) (2015 - 2024)

Company Filing History:

Institute for Advanced Study

patent

1 out of 2

Institute of Advanced Study

Years Active: 2015-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12123005 - Fusion proteins and methods thereof (2024-10-22),

2. 11920138 - Fusion proteins and methods thereof (2024-03-05),

3. 11505788 - Fusion proteins and methods thereof (2022-11-22),

4. 10815277 - Viral inhibitory nucleotide sequences and vaccines (2020-10-27),

5. 10208296 - Fusion proteins and methods thereof (2019-02-19),

6. 9574241 - [object Object] (2017-02-21),

7. 9422342 - Recoding method that removes inhibitory sequences and improves HIV gene expression (2016-08-23),

8. 9222137 - Method for monitoring minimal residual hairy cell leukemia (2015-12-29),

Title: Innovations by Raul Rabadan: A Pioneer in Cancer Research

Introduction

Raul Rabadan is a renowned inventor based in New York, NY, recognized for his significant contributions to cancer research through innovative technologies. With a total of eight patents to his name, Rabadan has established himself as a leader in the field of oncology, focusing on the mechanisms of gene-fusion based cancers.

Latest Patents

Among his most recent patents, Rabadan has developed methods relating to oncogenic fusion proteins. These groundbreaking inventions reveal new pathways for treating cancers that are characterized by gene fusions. His work emphasizes the potential of fusion proteins in cancer therapy, offering novel strategies for combating this complex disease.

Career Highlights

Throughout his career, Raul Rabadan has been affiliated with several prestigious organizations, including Columbia University and Trovagene, Inc. His involvement in these institutions has facilitated groundbreaking research and collaboration, advancing the understanding of cancer biology and the development of innovative treatments.

Collaborations

Rabadan has had the privilege of working alongside esteemed colleagues such as Antonio Iavarone and Anna Lasorella. This collaborative spirit has not only enriched his research endeavors but also fostered an environment of innovation that drives the field of cancer research forward.

Conclusion

Raul Rabadan's contributions to the field of oncology are underscored by his innovative patents and collaborative work with leading scientists. His dedication to developing effective treatments for gene-fusion based cancers continues to inspire and lead the way for future discoveries in the realm of medical research.

Profile summary based on public USPTO records.